Anti-Human CD4 D3 Domain Recombinant Antibody
-
产品编号
YR1157
-
别名
科研级 Ibalizumab ( 伊巴组单抗 ), Anti-CD4 D3 Domain Recombinant Antibody, Research Grade Ibalizumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1157 |
| Alias | 科研级 Ibalizumab ( 伊巴组单抗 ), Anti-CD4 D3 Domain Recombinant Antibody, Research Grade Ibalizumab |
| Size | 1mg, 5mg |
| Molecular Name | Ibalizumab |
| CAS Number | 680188-33-4 |
| Target | CD4 D3 domain[Homo sapiens] |
| Host | Mouse |
| Antibody Isotype | IgG4 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Ibalizumab (trade name Trogarzo) is a non-immunosuppressive humanised monoclonal antibody that binds CD4, the primary receptor for HIV, and inhibits HIV from entering cells. It is a post-attachment inhibitor, blocking HIV from binding to the CCR5 and CXCR4 co-receptors after HIV binds to the CD4 receptor on the surface of a CD4 cell. |
| Application | FuncS, IF, Neut, ELISA, FCM, IP, ICC |
| Remarks | This product is for research use only. |
0